- Adrenal Gland
- Long-Term Outcomes of Congenital Adrenal Hyperplasia
-
Anna Nordenström, Svetlana Lajic, Henrik Falhammar
-
Endocrinol Metab. 2022;37(4):587-598. Published online July 8, 2022
-
DOI: https://doi.org/10.3803/EnM.2022.1528
-
-
27,332
View
-
158
Download
-
3
Citations
-
 Abstract
 PDF PubReader  ePub  Crossref - TDM
- A plethora of negative long-term outcomes have been associated with congenital adrenal hyperplasia (CAH). The causes are multiple and involve supra-physiological gluco- and mineralocorticoid replacement, excess adrenal androgens both intrauterine and postnatal, elevated steroid precursor and adrenocorticotropic hormone levels, living with a congenital condition as well as the proximity of the cytochrome P450 family 21 subfamily A member 2 (CYP21A2) gene to other genes. This review aims to discuss the different long-term outcomes of CAH.
-
Citations
Citations to this article as recorded by  - Congenital adrenal hyperplasia: New biomarkers and adult treatments
Bleuenn Dreves, Yves Reznik, Antoine Tabarin
Annales d'Endocrinologie.2023;[Epub] CrossRef - Approach of Heterogeneous Spectrum Involving 3beta-Hydroxysteroid Dehydrogenase 2 Deficiency
Andreea Gabriela Nicola, Mara Carsote, Ana-Maria Gheorghe, Eugenia Petrova, Alexandru Dan Popescu, Adela Nicoleta Staicu, Mihaela Jana Țuculină, Cristian Petcu, Ionela Teodora Dascălu, Tiberiu Tircă
Diagnostics.2022; 12(9): 2168. CrossRef - Effetti di Crinecerfont sulla secrezione di ACTH nell’iperplasia surrenalica congenita: uno studio di fase 2
Marianna Rita Stancampiano, Silvia Laura Carla Meroni, Giovanna Weber, Gianni Russo
L'Endocrinologo.2022; 23(6): 662. CrossRef
|
KES
